Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases
出版年份 2023 全文链接
标题
Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases
作者
关键词
-
出版物
ANNALS OF MEDICINE
Volume 55, Issue 2, Pages -
出版商
Informa UK Limited
发表日期
2023-11-01
DOI
10.1080/07853890.2023.2273984
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Role of Adjuvant Chemotherapy in Stage I Pure Ovarian Immature Teratoma: A Systematic Review and Meta-Analysis
- (2023) Sijian Li et al. Cancers
- Surgical management and outcomes for stage 1 malignant ovarian germ cell tumours: A UK multicentre retrospective cohort study
- (2022) Radha Graham et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors
- (2021) Dimitrios Nasioudis et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
- (2021) Deborah K. Armstrong et al. Journal of the National Comprehensive Cancer Network
- Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999–2017
- (2021) Meerim Park et al. GYNECOLOGIC ONCOLOGY
- Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study
- (2021) Giorgia Mangili et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Pure pediatric ovarian immature teratomas: The French experience
- (2020) Rossana Pavone et al. PEDIATRIC BLOOD & CANCER
- Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery
- (2020) Dan Wang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis
- (2020) Alice Bergamini et al. EUROPEAN JOURNAL OF CANCER
- Retrospective Analysis of Pure Ovarian Immature Teratoma in Patients Aged 15–39 Years: A Turkish Multicenter Study
- (2020) Dilek Yüksel et al. Journal of Adolescent and Young Adult Oncology
- A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice
- (2019) C. Newton et al. EUROPEAN JOURNAL OF CANCER
- Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2018) I Ray-Coquard et al. ANNALS OF ONCOLOGY
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The role of staging and adjuvant chemotherapy in stage I Malignant ovarian germ cell tumors (MOGTs): the MITO-9 study
- (2016) G. Mangili et al. ANNALS OF ONCOLOGY
- Characteristics, treatment and outcomes of women with immature ovarian teratoma, 1998–2012
- (2016) Soledad Jorge et al. GYNECOLOGIC ONCOLOGY
- Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative
- (2015) Farzana Pashankar et al. CANCER
- Development of a risk stratification system to guide treatment for female germ cell tumors
- (2015) Jane L. Meisel et al. GYNECOLOGIC ONCOLOGY
- The significance of comprehensive staging surgery in malignant ovarian germ cell tumors
- (2013) Qian Liu et al. GYNECOLOGIC ONCOLOGY
- Rare cancers are not so rare: The rare cancer burden in Europe
- (2011) Gemma Gatta et al. EUROPEAN JOURNAL OF CANCER
- Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors
- (2011) Giorgia Mangili et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites
- (2007) D.M. PATTERSON et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started